Flow mediated dilatation in systemic sclerosis: Effects of iloprost treatment

被引：0
|
作者：
Giannattasio, C
Gentile, G
Failla, M
Pozzi, M
Gardinali, M
Meles, E
Zazzeron, C
Fantini, E
Maestroni, S
Mancia, G
机构：
[1] Clin Med Bicocca Univ, S Gerardo H, Monza, Italy
[2] S Gerardo H, Div Med 2, Monza, Italy
[3] Ist Interuniv Fisiol Clin Ipertens, Milan, Italy
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [21] Iloprost effects on the expression of adhesion molecules and T cell proliferaton in systemic sclerosis
    Rehberger, P.
    Beckheinrich, P.
    Haustein, U.
    Sticherling
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 429 - 429
  • [22] Iloprost Treatment in Systemic Sclerosis - Effects on Autonomic Nervous System Assessed through Heart Rate Variability Parameters
    Saramet, Elena Esmeralda
    Cojocaru, Doina-Clementina
    Ungurianu, Sorin
    Negne, Robert D.
    2020 INTERNATIONAL CONFERENCE ON E-HEALTH AND BIOENGINEERING (EHB), 2020,
  • [23] Iloprost effects on phenotypic activation of circulating T cells in patients with systemic sclerosis
    Bellissimo, S
    Iannone, SF
    Covelli, M
    Lapadula, G
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 220 - 221
  • [24] Iloprost treatment summer-suspension: effects on skin thermal properties and cytokine profile in systemic sclerosis patients
    Auriemma, M.
    Vianale, G.
    Reale, M.
    Costantini, E.
    Di Nicola, M.
    Romani, G. L.
    Merla, A.
    Muraro, R.
    Amerio, P.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2013, 148 (02): : 209 - 216
  • [25] Platelet indices as markers of inflammation in systemic sclerosis patients: Relation to vascular endothelial growth factor and flow mediated dilatation
    Ibrahim, Soha Eldessouki
    Morad, Caroline S.
    Farouk, Naglaa
    Louis, Amir
    EGYPTIAN RHEUMATOLOGIST, 2018, 40 (04): : 239 - 242
  • [26] Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis
    Cestelli, Valentina
    Manfredi, Andreina
    Sebastiani, Marco
    Praino, Emanuela
    Cannarile, Francesca
    Giuggioli, Dilia
    Ferri, Clodoveo
    MODERN RHEUMATOLOGY, 2017, 27 (01) : 110 - 114
  • [27] INTRAVENOUS ILOPROST TREATMENT SIDE EFFECT PROFILE IN PATIENTS WITH DIGITALULCERS DUE TO SYSTEMIC SCLEROSIS
    Ugurlu, S.
    Cevirgen, D.
    Yalcin, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S77 - S77
  • [28] PREDICTORS OF ILOPROST INFUSION TOLERANCE IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Bixio, R.
    Bertoldo, E.
    Giollo, A.
    Adami, G.
    Morciano, A.
    Bertelle, D.
    Gavioli, I.
    Orsolini, G.
    Viapiana, O.
    Rossini, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1473 - 1474
  • [29] Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al - Reply
    Tedeschi, A
    Meroni, PL
    Del Papa, N
    Boschetti, C
    Miadonna, A
    ARTHRITIS AND RHEUMATISM, 1999, 42 (01): : 197 - 198
  • [30] Thrombotic events in patients with systemic sclerosis treated with iloprost
    Tedeschi, A
    Meroni, PL
    Del Papa, N
    Salmaso, C
    Boschetti, C
    Miadonna, A
    ARTHRITIS AND RHEUMATISM, 1998, 41 (03): : 559 - 560
12345